Literature DB >> 20060006

Blood-brain barrier permeability and tPA-mediated neurotoxicity.

Rami Abu Fanne1, Taher Nassar, Sergei Yarovoi, Anwar Rayan, Itschak Lamensdorf, Michael Karakoveski, Polianski Vadim, Mahmud Jammal, Douglas B Cines, Abd Al-Roof Higazi.   

Abstract

Tissue type plasminogen activator (tPA) can induce neuronal apoptosis, disrupt the blood-brain barrier (BBB), and promote dilation of the cerebral vasculature. The timing, sequence and contributions of these and other deleterious effects of tPA and their contribution to post-ischemic brain damage after stroke, have not been fully elucidated. To dissociate the effects of tPA on BBB permeability, cerebral vasodilation and protease-dependent pathways, we developed several tPA mutants and PAI-1 derived peptides constructed by computerized homology modeling of tPA. Our data show that intravenous administration of human tPA to rats increases BBB permeability through a non-catalytic process that is associated with reversible neurotoxicity, brain damage, mortality and contributes significantly to its brief therapeutic window. Furthermore, our data show that inhibiting the effect of tPA on BBB function without affecting its catalytic activity, improves outcome and significantly extends its therapeutic window in mechanical as well as in thromboembolic models of stroke. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060006      PMCID: PMC4423729          DOI: 10.1016/j.neuropharm.2009.12.017

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  34 in total

1.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

2.  Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.

Authors:  M Renatus; R A Engh; M T Stubbs; R Huber; S Fischer; U Kohnert; W Bode
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

3.  Neutralizing the neurotoxic effects of exogenous and endogenous tPA.

Authors:  William M Armstead; Taher Nassar; Saed Akkawi; Douglas H Smith; Xiao-Han Chen; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Nat Neurosci       Date:  2006-09       Impact factor: 24.884

4.  Restoration of serine protease-inhibitor interaction by protein engineering.

Authors:  E L Madison; E J Goldsmith; M J Gething; J F Sambrook; R D Gerard
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

5.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

Authors:  M Yepes; M Sandkvist; M K Wong; T A Coleman; E Smith; S L Cohan; D A Lawrence
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

6.  LRP and alphavbeta3 mediate tPA activation of smooth muscle cells.

Authors:  Sa'ed Akkawi; Taher Nassar; Mark Tarshis; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-02-17       Impact factor: 4.733

7.  Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils. A role for defensin.

Authors:  A A Higazi; I I Barghouti; R Abu-Much
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

8.  Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion.

Authors:  Zhenjun Tan; Xinlan Li; Kimberly A Kelly; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2009-05-22       Impact factor: 3.252

9.  Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease.

Authors:  Xuesong Chen; Jeremy W Gawryluk; John F Wagener; Othman Ghribi; Jonathan D Geiger
Journal:  J Neuroinflammation       Date:  2008-04-03       Impact factor: 8.322

10.  A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

Authors:  Jae K Ryu; James G McLarnon
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310

View more
  29 in total

1.  Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.

Authors:  William M Armstead; John Riley; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

2.  Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Neurol Res       Date:  2012-05-30       Impact factor: 2.448

3.  Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier.

Authors:  Be'eri Niego; Robert L Medcalf
Journal:  J Vis Exp       Date:  2013-11-12       Impact factor: 1.355

4.  Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate.

Authors:  Rami Abu Fanne; Taher Nassar; Samuel N Heyman; Nuha Hijazi; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 5.  Cytoprotective-selective activated protein C therapy for ischaemic stroke.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Thromb Haemost       Date:  2014-09-18       Impact factor: 5.249

6.  tPA regulates pulmonary vascular activity through NMDA receptors.

Authors:  Taher Nassar; Khalil Bdeir; Serge Yarovoi; Rami Abu Fanne; Juan-Carlos Murciano; Steven Idell; Timothy Craig Allen; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

7.  The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.

Authors:  Maithili Sashindranath; Eunice Sales; Maria Daglas; Roxann Freeman; Andre L Samson; Elisa J Cops; Simone Beckham; Adam Galle; Catriona McLean; Cristina Morganti-Kossmann; Jeffrey V Rosenfeld; Rime Madani; Jean-Dominique Vassalli; Enming J Su; Daniel A Lawrence; Robert L Medcalf
Journal:  Brain       Date:  2012-07-20       Impact factor: 13.501

Review 8.  Desmoteplase: discovery, insights and opportunities for ischaemic stroke.

Authors:  Robert L Medcalf
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

9.  Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.

Authors:  Noëmie Jean LeBlanc; Romain Menet; Katherine Picard; Geneviève Parent; Marie-Ève Tremblay; Ayman ElAli
Journal:  Mol Neurobiol       Date:  2019-03-09       Impact factor: 5.590

Review 10.  Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?

Authors:  Be'eri Niego; Robert L Medcalf
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-04       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.